Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 11/20 | 0.40 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.38 |
| ▸ | SLC1A5 | Q15758 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.33 |
| ▸ | EDNRA | P25101 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7322275 | 1.00 | KIF11 (0.40) | KIF11SLC6A1SLC1A5LMNANPSR1 | |
| SCHEMBL7317519 | 0.88 | SLC6A1 (0.46) | KIF11SLC6A1SLC1A5SLC1A3SLC1A2 | |
| SCHEMBL7314653 | 0.88 | SLC6A1 (0.46) | KIF11SLC6A1SLC1A5SLC1A3SLC1A2 | |
| SCHEMBL7326447 | 0.87 | KIF11 (0.47) | KIF11SLC6A1SLC1A5LMNANPSR1 | |
| SCHEMBL7311726 | 0.87 | KIF11 (0.47) | KIF11SLC6A1SLC1A5 | |
| SCHEMBL7318344 | 0.87 | KIF11 (0.47) | KIF11SLC6A1SLC1A5 | |
| SCHEMBL7314762 | 0.85 | KIF11 (0.51) | KIF11SLC1A5 | |
| SCHEMBL7323248 | 0.84 | KIF11 (0.40) | KIF11SLC1A5LMNANPSR1EDNRB | |
| SCHEMBL7313387 | 0.81 | KIF11 (0.47) | KIF11SLC6A1SLC1A5 | |
| SCHEMBL7322735 | 0.80 | NPSR1 (0.36) | KIF11SLC6A1SLC1A5LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999041227-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-08-19 | — | — | WO | claimed |
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |